← FDA Drug Approvals (Drugs@FDA)
ARBLI
NDA · New Drug Application · Sponsor: SCIENTURE · Approved 2025-03-13
Drug application
- FDA Application #
NDA218772- Application type
- New Drug Application
- Brand name
- ARBLI
- Generic name
- LOSARTAN POTASSIUM
- Active ingredients
- LOSARTAN POTASSIUM
- Dosage form
- SUSPENSION
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- SCIENTURE
- Manufacturer
- Scienture LLC
- First approval
- 2025-03-13
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown